In 2020, AstraZeneca paid a total of ** billion U.S. dollars in upfront cash and equity for merger and acquisition deals, while Gilead paid nearly ** billion U.S. dollars. This statistic illustrates the top buyers in biopharma therapeutics and platforms, diagnostics, and medtech (also digital health) merger and acquisition deals worldwide in 2020, by upfront cash and equity paid.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
DealForma. (February 17, 2021). Leading buyers in biopharma, diagnostics, and medtech M&A deals worldwide in 2020, by upfront cash and equity paid* (in billion U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 06, 2026, from /statistics/1240320/top-buyers-biopharma-ma-deals-by-upfront-cash-and-equity-paid/
DealForma. "Leading buyers in biopharma, diagnostics, and medtech M&A deals worldwide in 2020, by upfront cash and equity paid* (in billion U.S. dollars)." Chart. February 17, 2021. ÌÇÐÄÆƽâ°æ. Accessed August 06, 2026. /statistics/1240320/top-buyers-biopharma-ma-deals-by-upfront-cash-and-equity-paid/
DealForma. (2021). Leading buyers in biopharma, diagnostics, and medtech M&A deals worldwide in 2020, by upfront cash and equity paid* (in billion U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 06, 2026. /statistics/1240320/top-buyers-biopharma-ma-deals-by-upfront-cash-and-equity-paid/
DealForma. "Leading Buyers in Biopharma, Diagnostics, and Medtech M&a Deals Worldwide in 2020, by Upfront Cash and Equity Paid* (in Billion U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 17 Feb 2021, /statistics/1240320/top-buyers-biopharma-ma-deals-by-upfront-cash-and-equity-paid/
DealForma, Leading buyers in biopharma, diagnostics, and medtech M&A deals worldwide in 2020, by upfront cash and equity paid* (in billion U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1240320/top-buyers-biopharma-ma-deals-by-upfront-cash-and-equity-paid/ (last visited August 06, 2026)
Leading buyers in biopharma, diagnostics, and medtech M&A deals worldwide in 2020, by upfront cash and equity paid* (in billion U.S. dollars) [Graph], DealForma, February 17, 2021. [Online]. Available: /statistics/1240320/top-buyers-biopharma-ma-deals-by-upfront-cash-and-equity-paid/
